Tracking a Life-Saving drug for mothers
NCT ID NCT07278037
Summary
This study looks back at medical records to see how often a drug called tranexamic acid (TXA) was given to mothers who had dangerous bleeding after a C-section. Researchers want to understand if the increased use of this drug, recommended by global health authorities since 2017, has led to better outcomes for mothers and babies. The study does not provide treatment; it only analyzes past care to inform future medical practice.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CESAREAN SECTION COMPLICATIONS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Siriraj Hospital
RECRUITINGBangkoknoi, Bangkok, 10700, Thailand
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.